|
Aug 14, 2012, 07.04 PM IST
Piramal Healthcare's consolidated net profit fell significantly to Rs 4 crore in the quarter ended June 2012 as against Rs 89 crore in a year ago period due to sharp spike in finance cost and exceptional expenses.
Consolidated net sales increased 63.3% to Rs 710.3 crore from Rs 435 crore during the same period. Finance cost jumped to Rs 87.52 crore from Rs 10.99 crore while other income declined to Rs 57.50 crore from Rs 76.39 crore year-on-year. Piramal Healthcare has reported exceptional expenses of Rs 126 crore in the first quarter of FY13. Revenues from pharmaceuticals manufacturing and services segment rose to Rs 672.90 crore from Rs 441.47 crore. Income from strategic investments went up to Rs 74.34 crore from Rs 70.48 crore YoY.
Related News Set email alert for Tags: Piramal Healthcare
|
Action in Piramal Enterprises
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
